BRD4 Silencing Protects Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting TLR4/NF-κB and Activating Nrf2-HO-1 Pathways

BACKGROUND: Heart failure is a critical health problem worldwide, and cardiac hypertrophy is an important characteristic of heart failure. Bromodomain-containing protein 4 (BRD4) is involved in various cellular processes, including cardiac hypertrophy. This study aimed to investigate the mechanism u...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Ming, Luo, Jun, Zhu, Xi, Wu, Yingbiao, Li, Xinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553838/
https://www.ncbi.nlm.nih.gov/pubmed/36247184
http://dx.doi.org/10.1155/2022/8372707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553838/
https://www.ncbi.nlm.nih.gov/pubmed/36247184
http://dx.doi.org/10.1155/2022/8372707

Ejemplares similares